We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

In this section

Shares

Stockbroker tips from ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Broker tips: Everplay, Kier

Wed 16 September 2026 15:31

(Sharecast News) - Analysts at Berenberg lifted their target price on video games developer Everplay from 370p to 495p, saying a stronger‑than‑expected franchise performance had prompted upgrades across its forecasts.

Deutsche Bank hikes Kier price target

Wed 16 September 2026 14:02

(Sharecast News) - Deutsche Bank hiked its price target on Kier on Wednesday to 330p from 295p after the company said a day earlier that 2027 earnings were set to be at the top end of its expectations, and that it will not be making any more investments i

Berenberg hikes target price on Everplay

Wed 16 September 2026 07:31

(Sharecast News) - Analysts at Berenberg lifted their target price on video games developer Everplay from 370p to 495p, saying a stronger‑than‑expected franchise performance had prompted upgrades across its forecasts.

Citi lifts price target on Vodafone, maintains 'neutral' rating

Tue 15 September 2026 14:14

(Sharecast News) - Citi lifted its price target on Vodafone on Tuesday to 127p from 110p as it said scope for positive news was stopping it from taking a more cautious stance.

Broker tips: GSK, Astrazeneca, Vodafone

Tue 15 September 2026 12:54

(Sharecast News) - Analysts at Berenberg upgraded drugmaker GSK from 'hold' to 'buy' on Tuesday and lifted their target price on the stock from £20 to £22, saying recent business‑development activity and pipeline momentum had strengthened the firm

Deutsche Bank upgrades Astrazeneca to 'hold'

Tue 15 September 2026 12:42

(Sharecast News) - Deutsche Bank upgraded Astrazeneca from 'sell' to 'hold' on Tuesday and nudged its price target up from 11,500p to 11,700p, saying the risk‑reward scenario had shifted following last week's negative SERENA-4 readout and a period of un

Berenberg upgrades GSK to 'buy', raises target price

Tue 15 September 2026 07:24

(Sharecast News) - Analysts at Berenberg upgraded drugmaker GSK from 'hold' to 'buy' on Tuesday and lifted their target price on the stock from £20 to £22, saying recent business‑development activity and pipeline momentum had strengthened the firm

Broker tips: Antofagasta, Cerillion

Mon 14 September 2026 13:59

(Sharecast News) - Analysts at Berenberg upgraded Antofagasta from 'hold' to 'buy' on Monday, saying last week's sharp pullback in copper prices had created an attractive entry point, while keeping its 4,400p price target unchanged for around 16% upside.

Canaccord Genuity lowers target price on Cerillion

Mon 14 September 2026 12:36

(Sharecast News) - Canaccord Genuity cut its price target on Cerillion from 2,060p to 1,760p on Monday, after the software group warned that second‑half trading would be weaker than expected, leading to revenue and underlying earnings misses against con

Berenberg upgrades Antofagasta to 'buy'

Mon 14 September 2026 07:48

(Sharecast News) - Analysts at Berenberg upgraded Antofagasta from 'hold' to 'buy' on Monday, saying last week's sharp pullback in copper prices had created an attractive entry point, while keeping its 4,400p price target unchanged for around 16% upside.